PERIODONTOLOGY 2000
vention. They are indeed correct and the effectiveness of osseointegrated implants is undisputed when going from a situation of total or partial edentulism with ill-tting dentures to a situation with xed implant-supported bridges. Observational studies evaluating patients before and after treatment with dental implants have demonstrated great advantages with regard to function, esthetics and psycho-social factors (9, 17). The large bulk of clinical follow-up studies generally show that implants, with some exceptions, are successful on most indications if the established standard protocols are followed (2, 13). Rightfully, it seems to be the opinion of the dental profession that osseointegrated implants is the rst choice for replacing one or several missing teeth, in spite of the lack of randomized controlled trials. However, it is not clear which type of implants and clinical techniques are superior to others and whether teeth should be extracted or not to make room for implants. Moreover, what is the long-term response to the surviving implants with regard to the health of the marginal bone and soft tissues (19)? These are some of the controversies and topics that will be discussed in this special issue on dental implants.
Sennerby
altering the components (15). Moreover, when 5-year and 10-year data were reported, the implant designs were still commercially available and used in patients. When the mechanisms behind osseointegration became better understood and when good long-term function had been proven, it was absolutely necessary to improve and simplify the clinical techniques involved. To take one example, the nemark standard abutment to change from the Bra the EsthetiCone was a signicant and unquestionable improvement as was the development of single tooth abutments (20, 33). Improvement of the surgical technique by introducing self-tapping implants has also been positive as has the introduction of narrow and wide implants based on the original implant design. At present, the situation is completely different and change is the only thing constant within implant dentistry. It is not uncommon that when a 3-year or a 5-year study is published, the implant component is already old and abandoned (7). Controlled clinical studies are necessary when evaluating new clinical techniques and novel implant components before their introduction to the market. How can we otherwise justify changing from one clinical technique component that works well to another? There is always a risk that the new undocumented component technique performs worse than the old one, which, in the end, will affect the patient. One recent example is the introduction of one-piece implants with a rough titanium surface against the mucosa, which was claimed to minimize bone resorption and to result in soft tissue integration (12). Some authors reported poorer clinical outcomes with this concept as extensive bone resorption was seen (4, 25, 30). The concept of soft tissue integration had not been heard of before and in fact it was well known that epithelial cells are rugophobic (i.e. they cannot attach to a rough surface) (11) and thus form a poor soft tissue barrier to the oral cavity, which may explain the reported extensive bone resorption. Again, very few controlled studies have been published and this is best explained by the lack of incentives. Controlled clinical studies are costly and resource-demanding and few noncommercial bodies or universities can afford to fund such studies. If funded by a company, the same company runs the risk that the product tested or new clinical technique promoted will not win against the previously used method or implemented strategy. In contrast to a pharmaceutical drug, the introduction of which requires years of clinical research, dental implants are devices and can in principle be registered and sold without any clinical documentation of
that very product. This means that dentists, who may have been seduced by skillful marketing, will take a risk and will be responsible in the event of complications. In the worst case, the result will be an unhappy patient who suffers from sequels related to an unproven component procedure. The doctor has, of course, the opportunity to wave a red ag and report the complications. However, if the product has been approved by a regulatory body, the risk of withdrawal from the market is negligible unless the documentation of complications is extensive or if patients die. Moreover, in view of the legaleconomic risks for the lonely clinician, not many doctors even consider protesting. One way to avoid the release of undocumented products is to apply stricter rules for new products. It seems reasonable to suggest that data from clinical studies on the product should be presented, preferably from independent clinics, before approval can be considered. The performance of approved implant components can be monitored by establishing databases where implant placements and failures complications can be reported. However, do we want more rules and restrictions? A better way would be for the industry to work in symbiosis with clinicians and researchers with the best for the patient in focus, rather than implementing ideas that make attractive marketing campaigns but are questionable from a scientic point of view. As suggested by Albrektsson et al. (5), It may be that the companies are motivated to form specic Scientic Advisory Boards if the governmental agencies in Europe and the USA decide to strengthen their demands on the marketing of oral implants. These devices are, after all, placed in humans and they are not necessarily without harm to patients if unsuitable designs and or placement strategies continue to be recommended. The implant manufacturers are important sources of nancial support for research and give inventors and researchers the opportunity to explore their ideas because few other bodies, such as national research councils and universities, support this kind of work. The incentive for the companies is of course to develop new products and to use the results from scientic work for marketing purposes in order to be as protable as expected by their shareholders. This mode of operation is not completely without risks and there may be a problem when interpreting results from experimental studies and extrapolating to the clinical situation. Are the parameters used in a study clinically relevant? One good example is implant surface modication, and it is a welldocumented fact that a slight increase of surface
10
roughness results in more and earlier boneimplant contacts as well as a higher resistance to removal torque forces (3). It is then easy to believe that such a surface would perform much better in the clinical situation than an implant with an as-machined surface. To the knowledge of the present author, the few randomized controlled trials available have not been able to demonstrate this, which was also the conclusion of a meta-analysis (14). So the main question is, will the patients notice a difference? Having said this, this author believes that surface modication results in better clinical outcomes in biologically challenging situations such as bone augmentation and immediate loading. The few randomized controlled trials comparing implant surfaces have used two-stage procedures in patients with good bone conditions. When evaluating the literature on implant treatment in more challenging situations, such as soft bone, immediate loading and bone grafting, it seems as if moderately rough implants perform better. However, randomized controlled trials are needed to prove this point scientically. The problem is that control implants with a machined surface are no longer commercially available because the general opinion is that surface-modied implants are better. At present, the third generation of implant surfaces is already a clinical and commercial reality, often based on nanotechnology. Although some of the experimental research is convincing, using parameters such as boneimplant contacts and removal torque (3), the inuence on the clinical outcomes is unknown. However, the new surfaces on well-documented implant designs are probably not hazardous for the patients and may result in a faster integration, which theoretically would allow for shorter healing periods prior to loading.
well documented and meticulous protocols and rather ceremonious clinical procedures were used in an attempt to avoid all imaginable complications. In essence, dental implants did not really compete with conventional prosthetic techniques but served as a solution for the hopeless cases. Currently, long-term clinical studies have shown that the use of osseointegrated implants results in highly predictable outcomes, and few risk factors for implant failure have been identied. The increased condence in osseointegration has widened the indications and positioned implants as the rst choice of treatment for partially edentulous patients and for single tooth gaps. Suddenly, treatment planning is much more complicated and often involves the decision to extract teeth which in fact may be treatable using conventional techniques to make room for implants. Can extractions on prosthetic indications be justied from a practical, economic and prognostic point of view, or should we look upon this as an amputation of a healthy limb? It is apparent from the literature that this is a controversial topic which is currently under debate (22).
11
Sennerby
implant surface is engaged with bone than if placed in a healed site, it is possible that the primary stability will be low. However, if it is possible to achieve good results using this technique, there are benets for the patients in terms of the shorter treatment time. Some authors claim that immediate implant placement will counteract resorption following extraction. However, available data are not conclusive and the method is still controversial. The clinical techniques for optimal placement of implant in extraction sockets, the effect on bone resorption and the clinical outcomes are discussed by Becker & Goldstein (8). The secondary stability depends on the bone tissue response during healing, and stability seems to increase with time for implants with low primary stability. If a certain degree of primary stability is achieved, it seems that the changes of stability as a result of healing are less marked. This means that such implants may be candidates for immediate early loading protocols. stman (26) In this volume of Periodontology 2000, O reviews the literature on immediate early loading and presents a protocol that is based on implant stability. It seems to be the general opinion that surface-modied implants are preferred because of their rapid integration.
If the available bone height in an area intended for implant placement is less than the shortest implant, a bone augmentation procedure is often considered. Moreover, it is generally anticipated that short implants are more prone to failure than longer implants, which is one further argument for a bone augmentation procedure in order to place long implants. This is especially common in the posterior maxilla where autogenous bone and bone substitutes are used for augmentation of the maxillary oor prior to, or in conjunction with, implant placement. Numerous techniques and grafting materials are available, as reviewed by Hallman & Thor (16). The use of endogenous platelet-rich plasma is one technique that has been evaluated. This is a biological technique employed to boost the incorporation of autogenous bone grafts using the patients own growth factors, which are found in the concentrate of trombocytes. The literature is not conclusive however, and little, if any, advantage with platelet-rich plasma has been demonstrated with regard to implant integration in maxillary sinus oor augmentation situations. However, platelet-rich plasma may serve as a glue for facilitating the handling of particulated bone grafts (16). The use of allogeneic, xenogeneic or alloplastic bone substitutes are also potentially attractive because no donor sites for autogenous bone grafts are needed. Apparently, good clinical outcomes can be obtained for maxillary sinus oor augmentation. In this volume of Periodontology 2000, Lundgren et al. (24) report on the experiences of a new technique for bone formation in the maxillary sinus without the use of any grafts. Using this technique, the sinus membrane is elevated and tented with surface modied implants and the space secluded with a replaceable bone window at the lateral aspect of the sinus wall. Predictable bone formation is shown from clinical radiographic examinations as well as from experimental studies in primates. Their results indicate an impressive healing capacity of the maxillary sinus, which may explain the generally good results obtained from various sinus lift procedures. From a historical point of view, it is correct that 7 nemark type implants with a machined surmm Bra face show higher failure rates than longer implants. However, retrospective analysis of more recent follow-up data points to no or only small differences between short implants and long implants (15). This may be related to improvements of surgical technique, where achievement of rm primary stability is strived for, and may also be explained by a positive bone response to the new modied implant surfaces.
12
One alternative to bone augmentation is thus to use short implants (15). Moreover, by using a bone safari technique (i.e. searching for bone using a thin spiral drill), long implants can be placed tilted (6, 15). Originally, nonaxial implants were regarded as biomechanically compromised; however, more recent understanding shows that as long as the head of the implant is under the occlusal plane, the position of the integrated implant body is not important. Comparative clinical studies have reported similar and sometimes better outcomes with tilted compared with axially placed implants (6).The ultimate version of this concept is the use of zygomatic implants, as reviewed by Aparicio & Hatano in this volume of Periodontology 2000 (6). This implant was originally developed for the treatment of maxillectomized patients where no other options for rehabilitation with xed epistheses and prostheses were at hand. Over the years, the technique has been developed to be used in patients with severe atrophy of the maxilla. A typical patient is treated with two zygomatic implants bilaterally and two to four implants in the pre-maxilla. According to Aparicio & Hatano, good clinical outcomes have been reported (6).
materials that is interesting in this respect as a result of their mechanical properties, tooth-like color and good biocompatibility. Aluminum oxide and zirconia abutments are already in clinical use, and ceramic implants made from zirconia are commercially available according to a review by Kohal et al. in this volume of Periodontology 2000 (21). Although promising short-term results are reported with ceramic implants, Kohal et al. does not currently recommend their clinical use. However, the research work continues. A most interesting topic in bone healing and implant integration research is the use of growth factors. These are powerful proteins that can initiate bone formation in soft tissue and bone tissues and it can be speculated that they may be used to improve bone healing and implant integration. However, although the possible clinical applications are numerous, their use is not completely without difculties and researchers have tried to nd clinical uses for bone growth factors since the discovery of bone morphogenetic proteins by Urist in 1965. Dosage, timing and the method of administration are some of the topics that have been addressed in various research projects. In order to become a viable commercial product, acquisition cost is also an issue. The history, problems, ndings from ongoing research projects and possible future use of bone growth factors are discussed by Huang et al. (18), who foresee that the ability to predictably induce osteogenesis through the use of bone morphogenetic protein technologies is not far from a clinical reality and will have a profound effect on clinical practice.
References
1. Albrektsson T, Zarb G, Worthington P, Eriksson AR. The long-term efcacy of currently used dental implants: a review and proposed criteria of success. Int J Oral Maxillofac Implants 1986: 1: 1125. 2. Albrektsson T, Sennerby L. State of the art in oral implants. J Clin Periodontol 1991: 18: 474481. 3. Albrektsson T, Wennerberg A. Oral implant surfaces Part I. Int J Prosth 2004: 17: 536564. stman PO, Rocci 4. Albrektsson T, Gottlow J, Meirelles L, O A, Sennerby L. Survival of Nobel Direct implants. An analysis of 550 consecutively placed implants at 18 different clinical centres. Clin Implant Dent Rel Res 2007: 9: 6570. 5. Albrektsson T, Sennerby L, Wennerberg A. State of the art of oral implants. Periodontol 2000 2008: 47: 1526. 6. Aparicio C, Ouazzani W, Hatano N. The use of zygomatic implants for prosthetic rehabilitation of the severely resorbed maxilla. Periodontol 2000 2008: 47: 162171.
13
Sennerby
n B, Bergendal T, Hallman M, 7. Astrand P, Engquist B, Anze Karlsson U, Kvint S, Lysell L, Rundcranz T. A three-year follow-up report of a comparative study of ITI Dental Im nemark System implants in the treatment of plants and Bra the partially edentulous maxilla. Clin Implant Dent Relat Res 2004: 6: 130141. 8. Becker W, Goldstein M. Immediate implant placement: treatment planning and surgical steps for successful outcome. Periodontol 2000 2008: 47: 7989. 9. Blomberg S, Lindquist LW. Psychological reactions to edentulousness and treatment with jawbone-anchored bridges. Acta Psychiatr Scand 1983: 68: 251262. nemark PI, Breine U, Adell R, Hansson BO, Lindstro m J, 10. Bra . Intraosseous anchorage of dental prostheses I. Ohlsson A Experimental studies. Scand J Plast Reconstr Surg 1969: 3: 8189. 11. Brunette DM. Principles of cell behavior on titanium surfaces and their application to implanted devices. In: Brunette DM, Tengvall P, Textor M, Thomsen P, editors. Titanium in medicine. Berlin: Springer Verlag, 2001: 485512. 12. Dragoo MR. Prototyp eines einteiligen implantats. DentalPraxis 2005: XXII: 319325. 13. Esposito M, Hirsch JM, Lekholm U, Thomsen P. Biological factors contributing to failures of osseointegrated oral implants. (I). Success criteria and epidemiology. Eur J Oral Sci 1998: 106: 527551. 14. Esposito M, Coulthard P, Thomsen P, Worthington HV. The role of implant surface modications, shape and material on the success of osseointegrated dental implants. A Cochrane systematic review. Eur J Prosthodont Restor Dent 2005: 13: 1531. 15. Friberg B. The posterior maxilla: clinical considerations nemark System implants. and current concepts using Bra Periodontol 2000 2008: 47: 6778. 16. Hallman M, Thor A. Bone substitutes and growth factors as an alternative complement to autogenous bone for grafting in implant dentistry. Periodontol 2000 2008: 47: 172192. 17. Haraldson T. Comparisons of chewing patterns in patients with bridges supported on osseointegrated implants and subjects with natural dentitions. Acta Odontol Scand 1983: 41: 203208. UME. Bone 18. Huang YH, Polimeni G, Quhash M, Wikesjo morphogenetic proteins and osseointegration: current knowledge future possibilities. Periodontol 2000 2008: 47: 206223. 19. Jemt T, Albrektsson T. Do long-term followed-up Branemark implants commonly show evidence of pathological bone breakdown? A review based on recently published data Periodontol 2000 2008: 47: 133142. 20. Kastenbaum F. Achieving ideal esthetics in osseointegrated prostheses. 1. Multiple units. Int J Periodontics Restorative Dent 1992: 12: 153159. chle M, Butz F. Ceramic abutments and 21. Kohal RJ, Att W, Ba ceramic oral implants. An update. Periodontol 2000 2008: 47: 224243. 22. Lundgren D, Rylander H, Laurell L. To save or to extract, that is the question. Natural teeth or dental implants in periodontitis-susceptible patients: clinical decision-making and treatment strategies exemplied with patient case presentations. Periodontol 2000 2008: 47: 2750. 23. Lundgren S, Cricchio G, Palma VC, Salata LA, Sennerby L. Sinus membrane elevation and simultaneous insertion of dental implants: a new surgical technique in maxillary sinus oor augmentation. Periodontol 2000 2008: 47: 193 205. stro m M, Nystro m E, Sennerby L. Strategies 24. Lundgren S, Sjo in reconstruction of the atrophic maxilla with autogenous bone grafts and endosseous implants. Periodontol 2000 2008: 47: 143161. stman PO, Hellman M, Albrektsson T, Sennerby L. 25. O Direct loading of Nobel Direct and Nobel Perfect one-piece implants: a 1-year prospective clinical and radiographic study. Clin Oral Implants Res 2007: 18: 409 418. stman PO. Immediate early loading of dental implants. 26. O Clinical documentation and presentation of a treatment concept. Periodontol 2000 2008: 47: 90112. 27. Palacci P, Nowzari H. Soft tissue enhancement around dental implants. Periodontol 2000 2008: 47: 113132. 28. Schroeder A, Pohler O, Sutter F. Gewebsreaktion auf ein che. Titan-Hohlzylinderimplantat mit Titan-Spritzobea Schweiz Mschr Zahnheilk 1976: 86: 713725. 29. Sennerby L, Roos J. Surgical determinants of clinical success of osseointegrated oral implants: a review of the literature. Int J Prosthodont 1998: 11: 408420. 30. Sennerby L, Rocci A, Becker W, Jonsson L, Johansson LA, Albrektsson T. Short-term clinical results of Nobel Direct implants: a retrospective multicentre analysis. Clinical Oral Implants Res 2008: 19: 219226. 31. Sennerby L, Meredith N. Implant stability measurements using resonance frequency analysis: biological and biomechanical aspects and clinical implications. Periodontol 2000 2008: 47: 5166. 32. Smith GCS, Pell JP. Parachute use to prevent death and major trauma related to gravitational challenge: systematic review of randomised controlled trials. British Med J 2003: 327: 14591461. 33. Spitzer D, Kastenbaum F, Wagenberg B. Achieving ideal esthetics in osseointegrated prostheses. Part II. The single unit. Int J Periodontics Restorative Dent 1992: 12: 500 507. 34. van Steenberghe D, Quirynen M, Molly L, Jacobs R. Impact of systemic diseases and medication on osseointegration. Periodontol 2000 2003: 33: 163171.
14